Additionally, genomic instability and oncogenic signaling pathways, such as the EGFRvIII-driven dysregulation of the receptor tyrosine kinase/mitogen-activated protein kinase (RTK/RAS/MAPK) pathway, fuel aggressive tumor behavior. Here, NTRK1 is linked to neoplasm.